Compounds For Use In The Treatment Of Erbb2+ Brain Cancer

Patent No. EP3400943 (titled "Compounds For Use In The Treatment Of Erbb2+ Brain Cancer") was filed by Array Biopharma on Mar 25, 2013. The application was issued on Dec 2, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZSep 1, 2021TER MEER STEINMEISTER & PARTNER
TEVA PHARMACEUTICALSSep 1, 2021KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3400943

ARRAY BIOPHARMA
Application Number
EP18162971A
Filing Date
Mar 25, 2013
Status
Revoked
Feb 8, 2025
Publication Date
Dec 2, 2020